Cargando…
Is sickle cell disease a risk factor for severe COVID‐19 outcomes in hospitalized patients? A multicenter national retrospective cohort study
INTRODUCTION: Studies that examine the association between sickle cell disease (SCD) and COVID‐19 outcomes are lacking. This study aims to determine whether SCD is a risk factor for severe COVID‐19 infection in regard to the requirement of noninvasive ventilation/high flow nasal cannula (NIV/HFNC),...
Autores principales: | Abdulrahman, Abdulkarim, Wael, Mohammed, AlAmmadi, Fajer, Almosawi, Zahra, Alsherooqi, Reem, Abduljalil, Manal, Kumar, Nitya, AlQahtani, Manaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014602/ https://www.ncbi.nlm.nih.gov/pubmed/33821258 http://dx.doi.org/10.1002/jha2.170 |
Ejemplares similares
-
Patterns of healthcare utilization among patients with sickle cell disease hospitalized with pain crises
por: Rodday, Angie Mae, et al.
Publicado: (2020) -
Alpha‐globin gene triplication and its effect in beta‐thalassemia carrier, sickle cell trait, and healthy individual
por: Hamid, Mohammad, et al.
Publicado: (2021) -
Clusters of pain trajectories among patients with sickle cell disease hospitalized for vaso‐occlusive crisis: A data‐driven approach
por: Rodday, Angie Mae, et al.
Publicado: (2020) -
Gabapentin for acute pain in sickle cell disease: A randomized double‐blinded placebo‐controlled phase II clinical trial
por: Puri, Latika, et al.
Publicado: (2021) -
In‐hospital mortality in SARS‐CoV‐2 stratified by hemoglobin levels: A retrospective study
por: Al‐Jarallah, Mohammed, et al.
Publicado: (2021)